Alps Advisors Inc Valneva Se Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$13.71 - $37.57 $738,982 - $2.03 Million
-53,901 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$27.0 - $50.99 $173,799 - $328,222
-6,437 Reduced 10.67%
53,901 $1.83 Million
Q4 2021

Feb 09, 2022
BUY
$27.1 - $67.28 $1.64 Million - $4.06 Million
60,338 New
60,338 $3.37 Million

Others Institutions Holding VALN

# of Institutions
11
Shares Held
718K
Call Options Held
0
Put Options Held
0
View Full List

About Valneva SE

VALN Quotes by TradingView
  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $322M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email